The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome.
Silverman, Robert H, Nguyen, Carvell, Weight, Christopher J et al. · Nature reviews. Urology · 2010 · DOI
Quick Summary
This review examines XMRV, a newly discovered virus that has been found in some people with prostate cancer and some with ME/CFS. Researchers have found the virus at very different rates in different studies (0-27% in prostate cancer, 0-67% in ME/CFS patients). While some antiviral drugs appear to block this virus, scientists still do not know whether XMRV actually causes either disease.
Why It Matters
This review is important because it documents early evidence of a potential viral cofactor in ME/CFS at a time when immune dysfunction mechanisms were being actively investigated. Understanding possible retroviral involvement could inform future diagnostic strategies and antiviral treatment approaches, and highlights the need for rigorous etiological research in ME/CFS.
Observed Findings
XMRV detected at variable rates: 0–27% in prostate cancer cases and 0–67% in ME/CFS patients across different studies
XMRV replication in prostate tissue may be stimulated by androgens through viral DNA transcriptional enhancer sites
Host restriction factors APOBEC3 and tetherin inhibit XMRV replication
Existing antiretroviral drugs show suppressive activity against XMRV in laboratory studies
Diagnostic assays for XMRV detection are under development
Inferred Conclusions
Immune dysfunction mediated by XMRV may represent a possible pathogenic factor in ME/CFS
Both direct carcinogenic mechanisms (in malignant epithelium) and indirect mechanisms (in stromal tissue) have been proposed for XMRV in prostate cancer
Comparative virology with animal gammaretroviruses suggests XMRV has potential to cause both cancer and neurological disease in humans
Therapeutic options targeting XMRV may become available pending confirmation of causal relationships
Remaining Questions
Does XMRV causally contribute to ME/CFS pathogenesis, or is detection merely coincidental or due to contamination?
What This Study Does Not Prove
This study does not prove that XMRV causes ME/CFS or prostate cancer. The wide variation in detection rates (0–67% in ME/CFS) across studies suggests methodological differences or contamination issues, and the review itself acknowledges that causality remains unknown. Correlation between viral presence and disease does not establish causation, and subsequent research raised significant questions about the validity of XMRV detection in these populations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.